Switched Aβ43 generation in familial Alzheimer's disease with presenilin 1 mutation

被引:6
|
作者
Kakuda, Nobuto [1 ,2 ]
Takami, Mako [1 ,2 ]
Okochi, Masayasu [3 ]
Kasuga, Kensaku [4 ]
Ihara, Yasuo [1 ]
Ikeuchi, Takeshi [4 ]
机构
[1] Doshisha Univ, Fac Life & Med Sci, Dept Neuropathol, Kyoto 6100394, Japan
[2] Doshisha Univ, Ctr Res Neurodegenerat Dis, Kyoto 6100394, Japan
[3] Osaka Univ, Grad Sch Med, Div Internal Med, Neuropsychiat & Neurochem,Dept Integrated Med, Osaka 5650871, Japan
[4] Niigata Univ, Ctr Bioresources, Bioresource Sci Branch, Dept Mol Genet, Niigata 9518585, Japan
关键词
GAMMA-SECRETASE ACTIVITY; AMYLOID-BETA-PROTEIN; INTRAMEMBRANE CLEAVAGE; TERMINAL FRAGMENT; SENILE PLAQUES; DEPOSITION; MECHANISM; RELEASE; DOMAIN; ONSET;
D O I
10.1038/s41398-021-01684-1
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Presenilin (PS) with a genetic mutation generates abundant beta-amyloid protein (A beta) 43. Senile plaques are formed by A beta 43 in the cerebral parenchyma together with A beta 42 at middle ages. These brains cause the early onset of Alzheimer's disease (AD), which is known as familial Alzheimer's disease (FAD). Based on the stepwise processing model of A beta generation by gamma-secretase, we reassessed the levels of A beta s in the cerebrospinal fluid (CSF) of FAD participants. While low levels of A beta 38, A beta 40, and A beta 42 were generated in the CSF of FAD participants, the levels of A beta 43 were unchanged in some of them compared with other participants. We sought to investigate why the level of A beta 43 was unchanged in FAD participants. These characteristics of A beta generation were observed in the gamma-secretase assay in vitro using cells, which express FAD mutations in PS1. A beta 38 and A beta 40 generation from their precursors, A beta 42 and A beta 43, was decreased in PS1 mutants compared with wild-type (WT) PS1, as observed in the CSF. Both the ratios of A beta 38/A beta 42 and A beta 40/A beta 43 in PS1 mutants were lower than those in the WT. However, the ratio of A beta 43/amyloid precursor protein intracellular domain (AICD) increased in the PS1 mutants in an onset age dependency, while other A beta/AICD ratios were decreased or unchanged. Importantly, liquid chromatography-mass spectrometry found that the generation of A beta 43 was stimulated from A beta 48 in PS1 mutants. This result indicates that PS1 mutants switched the A beta 43 generating line, which reflects the level of A beta 43 in the CSF and forming senile plaques.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Myoclonus in genetic Alzheimer's disease due to presenilin-1 mutation
    Uccellini, Davide
    Canafoglia, Laura
    Franceschetti, Silvana
    Stabile, Andrea
    Catania, Marcella
    Tagliavini, Fabrizio
    Giaccone, Giorgio
    Di Fede, Giuseppe
    CLINICAL NEUROPHYSIOLOGY, 2023, 156 : 86 - 88
  • [42] Presenilin-1 mutation Alzheimer's disease: A genetic epilepsy syndrome?
    Larner, A. J.
    EPILEPSY & BEHAVIOR, 2011, 21 (01) : 20 - 22
  • [43] Alzheimer's disease - Molecular consequences of presenilin-1 mutation - Reply
    Russo, C
    Schettini, G
    Saido, TC
    Hulette, C
    Lippa, C
    Lannfelt, L
    Ghetti, B
    Gambetti, P
    Tabaton, M
    Teller, JK
    NATURE, 2001, 411 (6838) : 655 - 656
  • [44] Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers
    Quiroz, Yakeel T.
    Stern, Chantal E.
    Reiman, Eric M.
    Brickhouse, Michael
    Ruiz, Adriana
    Sperling, Reisa A.
    Lopera, Francisco
    Dickerson, Bradford C.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (05): : 556 - 561
  • [45] Familial Alzheimer's Disease with Presenilin 2 N141I Mutation A Case Report
    Nikisch, G.
    Wiedemann, G.
    Kiessling, B.
    Hertel, A.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2008, 76 (10) : 606 - 609
  • [46] Familial Alzheimer's disease mutations enhance apoptotic effects of presenilin-1
    Kovacs, DM
    Mancini, R
    Na, S
    Kim, TW
    Tanzi, RE
    ALZHEIMER'S DISEASE AND RELATED DISORDERS: ETIOLOGY, PATHOGENESIS AND THERAPEUTICS, 1999, : 607 - 612
  • [47] Presenilin-1 gene intronic polymorphism in sporadic and familial Alzheimer's disease
    Sorbi, S
    Nacmias, B
    Tedde, A
    Forleo, P
    Piacentini, S
    Latorraca, S
    Amaducci, L
    NEUROSCIENCE LETTERS, 1997, 222 (02) : 132 - 134
  • [48] Missense mutations in the chromosome 14 familial Alzheimer's disease presenilin 1 gene
    Poorkaj, P
    Sharma, V
    Anderson, L
    Nemens, E
    Alonso, ME
    Orr, H
    White, J
    Heston, L
    Bird, TD
    Schellenberg, GD
    HUMAN MUTATION, 1998, 11 (03) : 216 - 221
  • [49] Clinical Phenotype of G206D Mutation in the Presenilin 1 Gene in Pathologically Confirmed Familial Alzheimer's Disease
    Wu, Ya-Ying
    Cheng, Irene Han-Juo
    Lee, Chin-Cheng
    Chiu, Ming-Jang
    Lee, Ming-Jen
    Chen, Ta-Fu
    Hsu, Jung-Lung
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 25 (01) : 145 - 150
  • [50] Association between presenilin-1 Glu318Gly mutation and familial Alzheimer's disease in the Australian population
    Taddei, K
    Fisher, C
    Laws, SM
    Martins, G
    Paton, A
    Clarnette, RM
    Chung, C
    Brooks, WS
    Hallmayer, J
    Miklossy, J
    Relkin, N
    St George-Hyslop, PH
    Gandy, SE
    Martins, RN
    MOLECULAR PSYCHIATRY, 2002, 7 (07) : 776 - 781